August 21, 2018
Lisa Folberg, MPP Will Be New CAFP EVP-CEO
Another reminder to members that Lisa Folberg, MPP has been selected as CAFP’s new Executive Vice President (EVP), after recommendation by the Academy’s Search Committee and final approval by the Board of Directors at its Saturday, July 14 meeting in Oakland. CAFP undertook a nationwide search to identify a successor to current EVP Susan Hogeland, CAE, who will retire on September 30 after 27 years with the Academy.
Ms. Folberg has 18 years of experience in government relations, management, health policy and program development and most recently served for three years as President and CEO of the California Medical Association Foundation (CMAF), now known as Physicians for a Healthy California. She helped build the Network of Ethnic Physician Organizations (NEPO) at CMAF. Previously, Ms. Folberg served as Vice President, Medical and Regulatory Policy and as Associate Director, Government Relations for the California Medical Association and as Senior Fiscal and Policy Analyst for the California Legislative Analyst’s Office. She received her undergraduate degree at San Francisco State University and her Master of Public Policy from Georgetown University.
Congratulations, Ms. Folberg, and welcome to CAFP. CAFP members are invited to send welcome emails to Ms. Folberg to email@example.com.
Catch Up on Latest Board Action on AMAM Resolutions
A complete list of Board action to date on resolutions submitted to it at the All Member Advocacy Meeting (AMAM) in March or subsequently has been posted on the CAFP website. It is updated after each meeting of the Board at which action is taken on resolutions. New resolutions must be posted for at least one month prior to Board meetings to allow time for member comment.
Have You Joined SPARK?
Join CAFP’s all-member online community, SPARK, to find answers to your everyday practice questions, share experiences and network with fellow family physicians in California. Log in today and join the conversation with hundreds of your colleagues. Check out this quick how-to video and get started in three simple steps.
Parkinson's Disease Reporting Mandate Reduced
CAFP has worked with a number of stakeholders to pressure the Department of Public Health (DPH) and the Governor’s office to reduce overly burdensome and unnecessary reporting requirements related to the collection of data for the California Parkinson’s Disease Registry. The Registry, which opened July 1, requires physicians, physician assistants and nurse practitioners who diagnose or treat Parkinson’s disease patients to register with DPH and report cases of Parkinson’s disease. The originally required 62 data fields have been narrowed to 14 with three optional fields, and a new Implementation Guide has been released. In addition to the reduced requirements, the reporting compliance date has been extended from 90 to 180 days until October 1, after which all cases must be reported within 90 days. If you treat this population, please familiarize yourself with the new implementation guide and see DPH’s “At a Glance” document.
CURES to Improve EHR Interoperability
Within the next month, the California Department of Justice (DoJ) is expected to publish an application program interface (API) which will allow health information technology companies to connect directly with the Controlled Substance Utilization Review and Evaluation System (CURES). This should allow health information exchanges (HIEs) and similar systems to connect to CURES, enabling providers to meet their obligation to check the CURES database from within their electronic health records (EHRs) without a separate sign-on. Beginning October 2, 2018, all DEA-registered physicians must register with and consult CURES prior to prescribing Schedule II, III or IV controlled substances to a patient for the first time, and at least once every four months thereafter if that substance remains part of the patient’s treatment. Physicians also must consult CURES no earlier than 24 hours, or the previous business day, before prescribing, ordering, administering or furnishing a controlled substance to the patient. Limited exemptions apply to these requirements. For more information on physician requirements, please review the California Medical Board’s CURES Factsheet.
CAFP Members Elected to AAFP Student-Resident Leadership Positions
Congrats to Anna Askari, MD, a first-year resident at Eisenhower Medical Center Family Medicine Residency Program, for being elected as Resident Chair of the 2019 National Conference of Family Medicine Residents and Medical Students.
Kudos! Julia Wang, a fourth-year medical student at USC Keck School of Medicine, was selected to serve as Student Delegate to the 2018 AAFP Congress of Delegates.
CMS to Host “Listening Session” on Medicare Fee Schedule
The Centers for Medicare and Medicaid Services (CMS) recently released the 2019 Draft Physician Fee Schedule and AAFP has prepared an initial summary of the regulations. CMS will host a “Three Key Topics Listening Session” on Wednesday, August 22 from 10:30 am - 12:00 pm. During the listening session, CMS experts will briefly cover three provisions from the proposed rule:
- Streamlining Evaluation and Management (E/M) payment and reducing clinician burden
- Advancing virtual care
- Continuing to improve the Quality Payment Program to reduce clinician burden, focus on outcomes and promote interoperability
AAFP and CAFP are working closely together to analyze the proposed rule and submit comments to ensure that they reflect organizational policy about providing value over volume of care. This is your opportunity to help formulate written comments for formal submission. If you have any concerns or comments about how the proposed fee schedule will affect your practice, please share them with CAFP.
In preparation for the session, CMS has provided:
- A Quality Payment Program Year 3 (2019) Webinar Recording, Transcript, Presentation and Comparison Fact Sheet
- A Slide presentation on E/M and Advancing Virtual Care
- E/M Coding Reform videos: Introduction, Office Visits and Panel Discussion
Feedback received during this listening session will not be considered formal comments on the rule.